These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. COX-2 inhibitors--second, do some good. Harrison A N Z Med J; 2005 Apr; 118(1212):U1395. PubMed ID: 15806191 [No Abstract] [Full Text] [Related]
8. Increased risk of cardiovascular events with coxibs and NSAIDs. Scott DG; Watts RA Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299 [No Abstract] [Full Text] [Related]
9. [A step back or training pain?]. Raeder J Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2050-1. PubMed ID: 16100553 [No Abstract] [Full Text] [Related]
10. [Insights and views about cardiovascular safety of COX2 inhibitors]. Wallentin L Lakartidningen; 2005 Feb 28-Mar 6; 102(9):666, 668, 671. PubMed ID: 15804041 [No Abstract] [Full Text] [Related]
11. COX-2 inhibitors: cancer prevention or cardiovascular risk? Senior K Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289 [No Abstract] [Full Text] [Related]
12. Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs. Stichtenoth DO; Frölich JC Age Ageing; 2004 Sep; 33(5):521. PubMed ID: 15315931 [No Abstract] [Full Text] [Related]
14. Discontinuation of Vioxx. Nutt DJ Lancet; 2005 Jan 1-7; 365(9453):28. PubMed ID: 15639676 [No Abstract] [Full Text] [Related]
15. [VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases]. Jerie P Cas Lek Cesk; 2005; 144(1):4. PubMed ID: 15789774 [No Abstract] [Full Text] [Related]
16. Life without COX 2 inhibitors: risks and benefits are determined by dose and potency. Sánchez-Delgado EJ BMJ; 2006 Jun; 332(7555):1451-2. PubMed ID: 16777893 [No Abstract] [Full Text] [Related]
18. COX-2 inhibitors and cardiovascular toxicity: a class effect? Laible B S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479 [No Abstract] [Full Text] [Related]
19. Don't throw out the baby with the bathwater! Kamen B; Kieran M J Pediatr Hematol Oncol; 2005 Feb; 27(2):59-60. PubMed ID: 15701976 [No Abstract] [Full Text] [Related]
20. Differences between COX-2-specific inhibitors: clinical and economic implications. Sonnenblick EH Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792 [No Abstract] [Full Text] [Related] [Next] [New Search]